Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:chemicalFormula |
C47H72O14
|
| gptkbp:hasFilm |
Diarrhea
Dizziness Nausea |
| gptkbp:hasWeight |
875.1 g/mol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avermectin 1a
|
| gptkbp:isAttendedBy |
gptkb:FDA
Livestock Humans Pets Oral tablet Formulation additives |
| gptkbp:isAvailableIn |
Prescription medication
|
| gptkbp:isChallengedBy |
Liver
|
| gptkbp:isEvaluatedBy |
Fungal infections
Nematodes Bacterial infections Viral infections Ectoparasites |
| gptkbp:isKnownFor |
Sustainability
High efficacy Low toxicity Environmental safety Broad-spectrum activity Resistance management |
| gptkbp:isPartOf |
Biotechnology
Pharmaceutical industry Insecticides Fungicides Antiparasitic agents Ivermectin family Chemical_industry Anthelmintic_drugs |
| gptkbp:isRecognizedFor |
Pregnant women
|
| gptkbp:isRelatedTo |
Ivermectin
Abamectin |
| gptkbp:isStudiedIn |
Room temperature
|
| gptkbp:isSuitableFor |
Fermentation process
|
| gptkbp:isUsedFor |
Parasitic infections
|
| gptkbp:isUsedIn |
Agriculture
Aquaculture Research Veterinary medicine Animal health Water treatment Crop protection Pest control Integrated pest management Human medicine Soil treatment |
| gptkbp:isValuedFor |
Streptomyces avermitilis
|